Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 275

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 275
---
 annual meeting of stockholders: Mr. Nicholas Fernandez and Dr. Ji Yeon Baek .

As a Class II director, with a term expiring at ParentCo’s 2027 annual meeting of stockholders: Dr. Eun Sook Lee .

As a Class III director, with a term expiring at ParentCo’s 2028 annual meeting of stockholders: Mr. Chris Kim .

See “ Management of ParentCo following the Business Combination — Board Composition ” for more information.

Notwithstanding the approval of the Election of Directors Proposal, if the Business Combination is not consummated for any reason, the actions contemplated by the Election of Directors Proposal will not be effected.

Following consummation of the Business Combination, the election of directors of ParentCo will be governed by the ParentCo Certificate of Incorporation, the ParentCo bylaws and the laws of the State of Delaware. Pursuant to the terms of the ParentCo Certificate of Incorporation, the term of the Class I director will expire at the 2026 annual meeting of stockholders, the term of the Class II director will expire at the 2027 annual meeting of stockholders, and the term of the Class III director will expire at the 2028 annual meeting of stockholders. If the Business Combination is consummated, ParentCo will plan to hold its first annual meeting of stockholders as a combined operating company in 2026.

#### Required Vote for Approval
The approval of the Election of Directors Proposal requires the affirmative vote of at least a plurality of the votes cast by stockholders present in person or represented by proxy at the Special Meeting and entitled to vote thereon, assuming a quorum is present. An abstention will be counted towards the quorum requirement but will not count as a vote cast at the Special Meeting. A broker non-vote will neither be counted towards the quorum requirement (as we believe the Election of Directors Proposal will be considered as non-discretionary) nor count as a vote cast in the Special Meeting. The stockholder votes regarding the Election of Directors Proposal are advisory votes and are not binding on us or our Board.

#### Recommendation of the Board

### THE IRIS BOARD UNANIMOUSLY RECOMMENDS THAT
<div align='center'>IRIS STOCKHOLDERS VOTE “FOR” EACH OF THE DIRECTOR NOMINEES NAMED ABOVE.

135</div>

TABLE OF CONTENTS

#### PROPOSAL NO. 7 — THE ADJOURNMENT PROPOSAL